Skip to main content
Download PDF
Download ePub

Determinants of survival following heart transplantation in adults with congenital heart disease

Journal of Cardiothoracic Surgery volume 19, Article number: 83 (2024) Cite this article

Abstract

Background

Adult patients surviving with congenital heart disease (ACHD) is growing. We examine the factors associated with heart transplant outcomes in this challenging population with complex anatomy requiring redo-surgeries.

Methods

We reviewed the United Network for Organ Sharing-Standard Transplant Analysis and Research database and analyzed 35,952 heart transplants from January 1st, 2000, to September 30th, 2018. We compared transplant characteristics for ischemic cardiomyopathy (ICM) (n = 14,236), nonischemic cardiomyopathy (NICM) (n = 20,676), and ACHD (n = 1040). Mean follow-up was 6.20 ± 4.84 years. Kaplan–Meier survival curves and Cox-proportional hazards analysis were used to analyze survival data.

Results

Multivariable analysis confirmed that ACHD was associated greater in-hospital death compared to ICM (HR = 0.54, P < 0.001) and NICM (HR = 0.46, P < 0.001). Notable factors associated with increased mortality were history of cerebrovascular disease (HR = 1.11, P = 0.026), prior history of malignancy (HR = 1.12, P = 0.006), pre-transplant biventricular support (HR = 1.12, P = 0.069), postoperative stroke (HR = 1.47, P < 0.001) and postoperative dialysis (HR = 1.71, P < 0.001). ACHD transplants had a longer donor heart ischemic time (P < 0.001) and trend towards more deaths from primary graft dysfunction (P = 0.07). In-hospital deaths were more likely with ACHD and use of mechanical support such as use of right ventricular assist device (HR = 2.20, P = 0.049), biventricular support (HR = 1.62, P < 0.001) and extracorporeal membrane oxygenation (HR = 2.36, P < 0.001). Conditional survival after censoring hospital deaths was significantly higher in ACHD (P < 0.001).

Conclusion

Heart transplant in ACHD is associated with a higher post-operative mortality given anatomical complexity but a better long-term conditional survival. Normothermic donor heart perfusion may improve outcomes in the ACHD population by reducing the impact of longer ischemic times.

Peer Review reports

Introduction

The most common congenital anomalies diagnosed at birth are congenital heart diseases (CHD) [1] and it affects about 1% of the ~ 40,000 births per year in the United States [2]. Modern advances in the surgical repair and management these defects in early life have allowed ~ 85–90% of children born with CHD to reach adult age [3, 4]. This achievement resulted in a large adult congenital heart disease (ACHD) population with congenitally corrected and/or palliated congenital cardiac conditions who need heart transplants [5]. The International Society for Heart and Lung Transplantation (ISHLT) 2018 registry reported that 3% of adult heart transplants between 2009 and 2017 were for ACHD [6] which is an increase from 2.7% between 2004 and 2008 [7]. Importantly, most transplant candidates with ACHD have single ventricles, a subgroup that is significantly more challenging than those with biventricular physiology [8].

Given the growing population of ACHD transplant candidates and the complexity of this patient population, identifying key outcomes determinants is critical for improving transplant outcomes. We examine the national Unified Organ Sharing Network (UNOS) database in detail to develop an understanding of the drivers of patient prognsosis and formulate management strategies to optimize transplant outcomes.

Patients and methods

Study population and data

We reviewed the United Network for Organ Sharing-Standard Transplant Analysis and Research (UNOS-STAR) database and analyzed 35,952 heart transplants from January 1st, 2000, to September 30th, 2018. For patients undergoing heart transplant for ischemic cardiomyopathy (ICM) (n = 14,236), nonischemic cardiomyopathy (NICM) (n = 20,676), and ACHD (n = 1,040), we compared recipient and donor characteristics as well as outcomes. The mean follow-up for the total study population was 6.20 ± 4.84 years. The University of Michigan institutional review board approved this study (IRB#HUM00194249).

Statistical methods

Categorical variables were compared using Pearson chi square test or Fisher’s exact test. Continuous variables were analyzed with Student’s t test or Analysis of variance (ANOVA) for more than 2 groups. Recipient demographics, clinical characteristics, hemodynamics, presentation characteristics and concomitant transplants as well as donor age, clinical features and blood type were analyzed using Cox proportional hazards to determine variables influencing survival. Univariable and multivariable forward and reverse logistic regression was used to evaluate for factors associated with mortality. Kaplan–Meier Survival analysis with Log-Rank statistics was also used to analyze survival data. Conditional survival based on survival to hospital discharge were also examined. A P value < 0.05 was considered statistically significant. Statistical analysis was performed using the Statistical Package for the Social Sciences software (SPSS Inc., Chicago, IL).

Results

Baseline characteristics

Compared to the ICM and NICM groups (Table 1), ACHD transplant recipients were younger (35.49 ± 12.99 years, P < 0.001), lower proportion of males (60.9%, P, 0.001), lower creatinine (1.21 ± 0.81 mg/dL, P < 0.001), higher bilirubin (1.21 ± 1.74 mg/dL, P < 0.001), less diabetes (5.1%, < 0.001), spent more days in status 2, less pre-transplant support with left and/or right ventricular assist devices. (P < 0.001), more likely to receive a concomitant liver transplant (4.9%, P < 0.001), lower mean pulmonary artery pressure (25.10 ± 9.74 mmHg, P < 0.001), and lower pulmonary capillary wedge pressures (16.91 ± 6.78 mmHg, P < 0.001). Compared with other groups, donors for ACHD patients were also younger (28.13 ± 11.23 years, P < 0.001), lower proportion of males (64.1%, P < 0.001), weighed less (74.99 ± 18.17 kg, P < 0.001) and had longer donor heart ischemic times (3.50 ± 1.15, P < 0.001).

Table 1 Heart failure group characteristics
Full size table

Survival

The mean follow-up for the entire study population (n = 35,952) was 6.20 ± 4.84 years. Univariable analysis for overall survival using Cox Proportional Hazards analysis of recipient, donor and transplant parameters are shown in Additional file 1: Table S1. Subsequent multivariable analysis (Additional file 1: Table S2) showed that ACHD diagnosis for transplantation had survival that was better when compared with ICM (HR = 1.18, P = 0.005) and similar when compared to NICM (HR = 0.917, P = 0.133). Kaplan–Meier survival analysis also demonstrates early mortality in the ACHD group with its survival curve in an “upward concave” shape (Fig. 1A). Other strong predictors of mortality in the total population included preoperative right ventricular assist device support (HR = 1.50, P = 0.041), preoperative biventricular support (HR = 1.20, P = 0.001), preoperative extracorporeal membrane oxygenation (HR = 1.60, P < 0.001), postoperative stroke (HR = 2.09, P < 0.001), postoperative dialysis (HR = 2.95, P < 0.001), and prolonged donor heart ischemic time (HR = 1.054, P < 0.001). Cumulative survival from 1 to 20 years are shown in Table 2 in each of the three heart failure groups. Impressively, ACHD patients who underwent transplant had a 20 year survival of 47%.

Fig. 1
figure 1

Long term survival of heart failure groups (A) and adjusted survival with censoring of in-hospital deaths (B)

Full size image
Table 2 Survival rates (5,10,15-year) in groups
Full size table

Next we censored patients who died in hospital during the initial transplant admission (n = 33,854). Univariable Cox Proportional Hazards analysis was performed in this group (Additional file 1: Table S3) followed by multivariable analysis (Table 3) which confirms that provided the patient survives the transplant admission episode, ACHD had superior survival compared to both ICM (HR = 1.54, P < 0.001) and NICM (HR = 1.17, P = 0.028). Other notable predictors of adjusted mortality included presence of cerebrovascular disease (HR = 1.11, P = 0.026), prior malignancy (HR = 1.12, P = 0.006), as well as postoperative stroke (HR = 1.47, P < 0.001) and dialysis (HR = 1.71, P < 0.001). The divergence in survival is clear from the conditional survival curve (Fig. 1B). ACHD had the best survival followed by NICM. ICM patients had the worse survival (P < 0.001, Fig. 1B).

Table 3 Multivariable cox proportional hazards analysis (forward and reverse stepwise regression) for long term survival after censoring in-hospital deaths
Full size table

Given they ACHD patient had excellent survival once out of hospital, we compared the predictors of in-hospital transplant death. Univariable analysis was performed (Additional file 1: Table S4) followed by multivariable evaluation (Table 4) revealed that ACHD was a strong predictor of in-hospital mortality during index transplant admission compared to ICM (HR = 0.54, P < 0.001) and NICM (HR = 0.46, P < 0.001). Other predictors of mortality included a higher bilirubin (HR = 1.09, P < 0.001), preoperative right ventricular assist device (HR = 2.20, P = 0.049), preoperative biventricular support (HR = 1.62, P < 0.001), preoperative extracorporeal membrane oxygenation (HR = 2.36, P < 0.001), postoperative stroke (HR = 4.42, P < 0.001), postoperative dialysis (HR = 12.92, P < 0.001), and prolonged donor heart ischemic time (P = 1.20, P < 0.001). Donor O blood type was also associated with higher mortality compared with blood type A (HR = 0.82, P = 0.001), B (HR = 0.82, P = 0.029), and AB (HR = 0.66, P = 0.051). Factors associated with survival included increasing donor/recipient body mass index ratio (HR = 0.51, P < 0.001), male donors (HR = 0.85, P = 0.011) and donors cocaine use (HR = 0.826, P = 0.012).

Table 4 Multivariable binary logistic regression for in-hospital death
Full size table

Cox Proportional hazard analysis also showed recent improvements in survival for ACHD transplantation in 2010–2018 (n = 594) compared to 2000–2009 (n = 446, HR = 0.699, P = 0.002). It is important to note that combined heart-liver transplants are performed much more frequently in ACHD compared with Ischemic (5.1% vs. 0.2%, P < 0.001) and Nonischemic (5.1% vs. 0.1%, P < 0.001) etiologies. However, survival after combined heart-liver transplantation did not differ between ACHD versus ischemic (HR = 1.6, P = 0.306) nor nonischemic (HR = 1.3, P = 0.461) pathologies.

Postoperative complications and cardiac retransplantation

ACHD had a higher rate of stroke (3.5%, P < 0.001) as well as a trend towards higher rates of death from primary graft dysfunction (2.3%, P = 0.007, Table 2). ACHD has higher rates of postoperative dialysis compared to NICM (20.6% vs. 10.0%, P < 0.001). There was a trend toward higher rates of death from primary graft failure in the ACHD group (2.3%, P = 0.071). Interestingly, ICM patients had lower rates of death from acute rejection (1.1%, P < 0.001). ACHD patients had the highest rate of retransplantation (2.8%, P < 0.001) followed by NICM (1.8%) and then finally ICM (0.9%). Kaplan-Meieer curve for retranplantation is shown in Fig. 2.

Fig. 2
figure 2

Freedom from retransplantation stratified by underlying diagnosis, either patients with adult congenital heart disease (ACHD), ischemic cardiomyopathy (ICM) or nonischemic cardiomyopathy (NICM)

Full size image

Discussion

Heart transplantation in ACHD patients presents unique challenges. In the 1950s, only 30% of births with congenital heart disease survived beyond infancy [9]. Currently, about 85–90% survive into adolescence and adulthood [4, 10]. It is estimated that about 10–20% of patients with congenital heart disease will need heart tranaplantation at some point although it is likely high in the contemporary setting [11, 12]. Most recipients with ACHD also have prior cardiac surgery and complex anatomy requiring obligate reconstructive surgery in more than 75% of these individuals operation. These may include extensive reconstructions of the aortic arch, vena cava, and/or pulmonary arteries [13]. Redo-sternotomies and additional procedural complexity contributes to longer cardiopulmonary bypass times with associated operative coagulopathy [8]. Additional factors inpacting early outcomes in ACHD patients include single ventricle physiology, more previous cardiac surgeries, presence of protein-losing enteropathy, and sensitization to alloantigens [14].

Not surprisingly, ACHD patients have a distinct profile consisting of different baseline characteristics than ICM and NICM groups. ACHD patients have favorable features such as tendency to be younger, with better renal function, lower pulmonary artery pressure and less ventricular assist device use pre-transplant. However, this is negatively counteracted by the greater operative complexity and more liver dysfunction as indicated by higher bilirubin. Although younger donor hearts were used in the ACHD population, these were subjected to a longer ischemic time. This risk profile with greater anatomical complexity is consistent with our finding that early mortality is higher in the ACHD group. First year survival was worse for ACHD (83.4%) compared with ICM (88.6%) and NICM (88.6%). Based on our conditional survival with censoring of deaths during the index transplant admission (Fig. 1B), ACHD patients benefit from much better long term survival provided they survive the initial transplant surgery and admission. Compared to ACHD the relative risk of mortality was 1.5 times for ICM and 1.2 times for NICM. Not surprisingly, long term mortality was highly associated with the occurrence of postoperative stroke (HR = 1.47) and postoperative dialysis (HR = 1.71). Given the younger age of ACHD patients, this group is much more likely to undergo retransplantation (Fig. 2). Other groups have also noted the initial surgical risks but increased long term transplant survival of ACHD patients given their young age [15,16,17,18]. Our study further defines the need to anticipate future cardiac retransplantation and the need for close management to optimize the graft survival duration in this population (Table 5).

Table 5 Post-transplant outcomes of heart failure groups
Full size table

Given these findings, we determined the the factors influencing operative or in-hospital survival. ACHD was highly associated with index transplant in-hospital mortality compared with ICM (HR = 0.54) and NICM (HR = 0.46). Other prominent factors associated with mortality included mechanical circulatory support such as right ventricular assist device use (HR = 2.20), biventricular support (HR = 1.62) and extracorporeal membrane oxygenation (HR = 2.36). Again the postoperative stroke (HR = 4.42) and dialysis (HR = 12.92) were important drivers of mortality. The higher incidence of stroke in ACHD may reflect the presence of residual shunts and thromboembolic substrates such as venous collaterals. Preemptive closure of shunts via transcatheter approaches and early cross clamp of the aorta during the transplant may help minimize stroke risk.

The longer donor heart ischemic time in the ACHD also translated into more deaths from primary graft dysfunction in this group. This suggests that the recent availability of commercial normothermic or hypothermic machine perfusion used for donor organ transport may mitigate against the effects of prolonged ischemic times in this ACHD group of patients requiring complex operative intervention and incurring longer operative times [19,20]. The higher incidence of death from acute rejection in the ACHD versus ischemic heart disease group as well as more combined heart-liver transplantation in the ACHD population may also have contributed to reduced short term survival. However, our demonstrated improvements in ACHD survival over time era likely reflects advancements in surgical expertise and medical management (Additional file 1).

Study limitations are that the UNOS database does not provide sufficient granularity to identify ACHD subtypes such as single ventricle physiology, Epstein’s Anomaly, or transposition of great arteries. Furthermore, the population of ACHD undergoing heart transplantation is relatively small and limits the power of the study to perform more detailed analysis.

In conclusion, we found that although adult ACHD patients had a higher early mortality rate after heart transplantation, and they had better long-term survival compared to non-ACHD recipients. This can be explained by the higher operative mortality given physiologcal and anatomical complexity of ACHD patients but a favorable longer term survival given their younger age provided operative survival was achieved. The longer donor heart ischemic times in ACHD resulting primary graft dysfunction was a major driver of the operative risk. More liberal use of modern normothermic perfusion transport techniques may mitigate the risk of primary graft dysfunction in this population.

Availability of data and materials

The data underlying this article will be shared on reasonable request to the corresponding author.

References

  1. Dolk H, Loane M, Garne E. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation. 2011;123(8):841–9. https://doi.org/10.1161/circulationaha.110.958405.

    Article  PubMed  Google Scholar 

  2. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998–2005. J Pediatr. 2008;153(6):807–13. https://doi.org/10.1016/j.jpeds.2008.05.059.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Crumb SR, Cook SC, Cheatham JP, et al. Quality outcomes of ACHD patients undergoing cardiovascular procedures and hospital admissions in a free-standing children’s hospital. Int J Cardiol. 2011;146(3):326–9. https://doi.org/10.1016/j.ijcard.2009.07.007.

    Article  PubMed  Google Scholar 

  4. Bhatt AB, Foster E, Kuehl K, et al. Congenital heart disease in the older adult: a scientific statement from the American Heart Association. Circulation. 2015;131(21):1884–931. https://doi.org/10.1161/CIR.0000000000000204.

    Article  PubMed  Google Scholar 

  5. Goldberg SW, Fisher SA, Wehman B, Mehra MR. Adults with congenital heart disease and heart transplantation: optimizing outcomes. J Heart Lung Transpl. 2014;33(9):873–7. https://doi.org/10.1016/j.healun.2014.05.001.

    Article  Google Scholar 

  6. Khush KK, Cherikh WS, Chambers DC, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-fifth adult heart transplantation report-2018; focus theme: multiorgan transplantation. J Heart Lung Transpl. 2018;37(10):1155–68. https://doi.org/10.1016/j.healun.2018.07.022.

    Article  Google Scholar 

  7. Lund LH, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: thirty-second official adult heart transplantation report–2015; focus theme: early graft failure. J Heart Lung Transpl. 2015;34(10):1244–54. https://doi.org/10.1016/j.healun.2015.08.003.

    Article  Google Scholar 

  8. Hosseinpour AR, Cullen S, Tsang VT. Transplantation for adults with congenital heart disease. Eur J Cardio Thorac Surg. 2006;30(3):508–14. https://doi.org/10.1016/j.ejcts.2006.06.007.

    Article  Google Scholar 

  9. Macmahon B, McKeown T, Record RG. The incidence and life expectation of children with congenital heart disease. Br Heart J. 1953;15(2):121–9. https://doi.org/10.1136/hrt.15.2.121.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Somerville J. Management of adults with congenital heart disease: an increasing problem. Annu Rev Med. 1997;48:283–93. https://doi.org/10.1146/annurev.med.48.1.283.

    Article  CAS  PubMed  Google Scholar 

  11. Penkoske PFR, Rowe R, Trusler G. The future of heart and heart—lung transplantation in children. Heart Transpl. 1984;3:233–8.

    Google Scholar 

  12. Nieminen HP, Jokinen EV, Sairanen HI. Causes of late deaths after pediatric cardiac surgery: a population-based study. J Am Coll Cardiol. 2007;50(13):1263–71. https://doi.org/10.1016/j.jacc.2007.05.040.

    Article  PubMed  Google Scholar 

  13. Lamour JM, Addonizio LJ, Galantowicz ME, et al. Outcome after orthotopic cardiac transplantation in adults with congenital heart disease. Circulation. 1999;100(19 Suppl):Ii00-5. https://doi.org/10.1161/01.cir.100.suppl_2.ii-200.

    Article  Google Scholar 

  14. Schumacher KR, Yu S, Butts R, et al. Fontan-associated protein-losing enteropathy and post-heart transplant outcomes: a multicenter study. J Heart Lung Transpl. 2019;38(1):17–25. https://doi.org/10.1016/j.healun.2018.09.024.

    Article  Google Scholar 

  15. Dolgner SJ, Nguyen VP, Krieger EV, Stempien-Otero A, Dardas TF. Long-term adult congenital heart disease survival after heart transplantation: a restricted mean survival time analysis. J Heart Lung Transpl. 2021;40(7):698–706. https://doi.org/10.1016/j.healun.2021.02.019.

    Article  Google Scholar 

  16. Huntley GD, Danford DA, Menachem J, Kutty S, Cedars AM. Donor characteristics and recipient outcomes after heart transplantation in adult congenital heart disease. J Am Heart Assoc. 2021;10(14):e020248. https://doi.org/10.1161/JAHA.120.020248.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Kinsella A, Rao V, Fan CP, et al. Post-transplant survival in adult congenital heart disease patients as compared to dilated and ischemic cardiomyopathy patients; an analysis of the thoracic ISHLT registry. Clin Transpl. 2020. https://doi.org/10.1111/ctr.13985.

    Article  Google Scholar 

  18. Doumouras BS, Alba AC, Foroutan F, Burchill LJ, Dipchand AI, Ross HJ. Outcomes in adult congenital heart disease patients undergoing heart transplantation: a systematic review and meta-analysis. J Heart Lung Transpl. 2016;35(11):1337–47. https://doi.org/10.1016/j.healun.2016.06.003.

    Article  Google Scholar 

  19. Bryner BS, Schroder JN, Milano CA. Heart transplant advances: Ex vivo organ-preservation systems. JTCVS Open. 2021;8:123–7. https://doi.org/10.1016/j.xjon.2021.04.020.

    Article  PubMed  PubMed Central  Google Scholar 

  20. McGiffin DC, Kure CE, Macdonald PS, et al. Hypothermic oxygenated perfusion (HOPE) safely and effectively extends acceptable donor heart preservation times: Results of the Australian and New Zealand trial. J Heart Lung Transpl. 2023. https://doi.org/10.1016/j.healun.2023.10.020.

    Article  Google Scholar 

Download references

Funding

This study is partially supported by the National Heart, Lung and Blood Institute of the National Institutes of Health grants R01HL166140 and R01HL164416 to Paul C. Tang.

Author information

Authors and Affiliations

  1. Department of Cardiac Surgery, University of Michigan Frankel Cardiovascular Center, Ann Arbor, MI, USA

    Hüseyin Sicim, Suyash Naik, Vikram Sood, Richard G. Ohye, Jonathan W. Haft, Francis D. Pagani & Paul C. Tang

  2. Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA

    Hüseyin Sicim & Paul C. Tang

  3. Department of Cardiac Surgery, Université de Montréal, Montréal, QC, Canada

    Pierre Emmanuel Noly

  4. Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Frankel Cardiovascular Center, Ann Arbor, MI, USA

    Keith D. Aaronson

  5. Department of Surgery, Division of Cardiac Surgery, University of California Los Angeles, Los Angeles, CA, USA

    Ming-Sing Si

Authors
  1. Hüseyin Sicim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierre Emmanuel Noly
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Suyash Naik
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vikram Sood
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Richard G. Ohye
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jonathan W. Haft
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Keith D. Aaronson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Francis D. Pagani
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ming-Sing Si
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Paul C. Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

We have included 10 authors for the following reasons. Dr. HS, and Dr. PCT were involved in the conception and design, manuscript drafting, analysis and interpretation of the data, data collection, as well as critical revision for important intellectual content. Dr. M-SS, Dr. PEN, Dr. RO, Dr. KA, Dr. JH, Dr. FDP, Dr. VS and SN were involved in the interpretation of data as well as critical revision for important intellectual content.

Corresponding author

Correspondence to Paul C. Tang.

Ethics declarations

Ethics approval and consent to participate

The University of Michigan institutional review board approved this study (IRB#HUM00194249).

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

Multivariable and univariate cox proportional hazards analysis for long term survival and univariate binary logistic regression for in-hospital death.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sicim, H., Noly, P.E., Naik, S. et al. Determinants of survival following heart transplantation in adults with congenital heart disease. J Cardiothorac Surg 19, 83 (2024). https://doi.org/10.1186/s13019-024-02509-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13019-024-02509-0

Keywords

Journal of Cardiothoracic Surgery

ISSN: 1749-8090

Contact us